1137637004: Naxitamab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Antineoplastic agent (substance)\Naxitamab
\Drug or medicament (substance)\Monoclonal antibody\Naxitamab

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Naxitamab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Naxitamab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Naxitamab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Naxitamab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Naxitamab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4526651015 Naxitamab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4526652010 Naxitamab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4526651015 Naxitamab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4526652010 Naxitamab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Naxitamab	Is a	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Naxitamab	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Naxitamab-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Naxitamab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Naxitamab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Naxitamab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing naxitamab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Naxitamab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only naxitamab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Naxitamab	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets